Oncology & Cancer

New cancer fears in France over breast implants (Update)

France's national cancer institute said on Tuesday there was a "clearly established link" between a rare form of cancer and a certain type of breast implant, as the health minister sought to allay fears.

Oncology & Cancer

Scientists make breakthrough in understanding of rare blood cancer

A breakthrough in understanding of a rare form of blood cancer could lead to significant improvements in treatment for patients. Scientists from the University of Southampton announced their findings at a prestigious scientific ...

Oncology & Cancer

Study offers clues to how breast implants may cause lymphoma

(Medical Xpress)—There have been 71 known cases worldwide of a type of blood cancer called anaplastic large cell lymphoma (ALCL) that the researchers suggest were associated with the patient's breast implants. This means ...

Oncology & Cancer

Predicting aggressive lymphoma

Each year, more than one thousand Norwegians develop lymphoma. A statistical genetic analysis can detect when the disease will be aggressive. Thereby, treatment can be initiated in time.

Oncology & Cancer

Beleodaq approved for aggressive non-hodgkin lymphoma

(HealthDay)—Beleodaq (belinostat) has been approved by the U.S. Food and Drug Administration to treat peripheral T-Cell lymphoma (PTCL), a rare and aggressive form of non-Hodgkin lymphoma (cancer of the lymph nodes).

Oncology & Cancer

New cancer drug shows promise in first trial outside the US

(Medical Xpress)—A cancer patient from Bolton with a rare form of Non-Hodgkin's Lymphoma is in remission after becoming the first person outside of the US to trial a new cancer drug, Brentuximab Vedotin, led by University ...

page 12 from 18